UMIN ID: UMIN000050602
Registered date:16/03/2023
Pharmacokinetic model for Remimazolam in patients undergoing cardiac surgery
Basic Information
| Recruitment status | Recruiting |
|---|---|
| Health condition(s) or Problem(s) studied | aortic valve disease |
| Date of first enrollment | 2023/03/16 |
| Target sample size | 10 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Remimazolam is administered to patients undergoing cardiac surgery and arterial blood draws are performed as appropriate. Blood draws should be performed only during surgery. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 90years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | BMI >30 kg/m2, BMI <18 kg/m2, pregnant, myasthenia gravis, acute angle closure glaucoma, patients with severe hepatic dysfunction, emergency surgery |
Related Information
| Primary Sponsor | Asahikawa Medical University |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Japan Science and Technology Agency |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Ami Sugawara |
| Address | 2-1-1-1, Midorigaoka-higasi, Asahikawa Japan 0788510 |
| Telephone | 0166652111 |
| asugawara@asahikawa-med.ac.jp | |
| Affiliation | Asahikawa Medical University Department of Anesthesiology and Critical Care Medicine |
| scientific contact | |
| Name | Ami Sugawara |
| Address | 2-1-1-1, Midorigaoka-higasi, Asahikawa Japan |
| Telephone | 0166652111 |
| asugawara@asahikawa-med.ac.jp | |
| Affiliation | Asahikawa Medical University Department of Anesthesiology and Critical Care Medicine |